Prostatis Group’s iShares S&P Small-Cap 600 Value ETF IJS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Sell
15,862
-401
-2% -$51.7K 0.5% 45
2026
Q1
$1.93M Buy
16,263
+4,034
+33% +$487K 0.49% 50
2025
Q4
$1.39M Buy
12,229
+6,441
+111% +$722K 0.33% 63
2025
Q3
$640K Sell
5,788
-7
-0.1% -$743 0.16% 90
2025
Q2
$577K Buy
5,795
+3,225
+125% +$305K 0.17% 91
2025
Q1
$251K Buy
2,570
+698
+37% +$73.6K 0.08% 134
2024
Q4
$203K Buy
+1,872
New +$207K 0.06% 151
2023
Q3
Sell
-11,607
Closed -$12.2K 163
2023
Q2
$12.2K Buy
+11,607
New +$1.06M 0.01% 243
2020
Q1
Sell
-42,208
Closed -$3.39M 68
2019
Q4
$3.39M Buy
+42,208
New +$3.27M 3.07% 11

Other funds holding IJS

Prostatis Group's IJS Position: Q2 2026 in Review

Prostatis Group reduced its iShares S&P Small-Cap 600 Value ETF (IJS) stake by 2.5% in Q2 2026, selling an estimated $51.7K and leaving 15,862 shares worth $2.17M. The position accounts for 0.5% of the portfolio, ranked #45.

Prostatis Group first reported a position in IJS in Q4 2019 and has held it in 9 quarters since. The position peaked at $3.39M in Q4 2019. 884 funds tracked by Wall St. Rank hold IJS as of Q2 2026.

  • Prostatis Group held 15,862 shares of iShares S&P Small-Cap 600 Value ETF worth $2.17M as of Q2 2026.
  • Prostatis Group sold 401 iShares S&P Small-Cap 600 Value ETF shares in Q2 2026, an estimated $51.7K.
  • iShares S&P Small-Cap 600 Value ETF made up 0.5% of Prostatis Group's portfolio in Q2 2026, its #45 holding.
  • Prostatis Group first reported a position in iShares S&P Small-Cap 600 Value ETF in Q4 2019 and has held it in 9 quarters since.
  • Prostatis Group's iShares S&P Small-Cap 600 Value ETF position peaked at $3.39M in Q4 2019.
  • 884 funds tracked by Wall St. Rank held iShares S&P Small-Cap 600 Value ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.